Advanced Search

Journal Navigation

Journal Home



Contact Us

Table of Contents

Click here to register today!

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viklicky, O.
Right arrow Articles by Vítko, S.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Graft, Vol. 5, No. 3, 179-181 (2002)
DOI: 10.1177/1522162802005003015
© 2002 SAGE Publications

Markers of Atherogenesis in Patients with Chronic Rejection of Renal Allografts

Ondfiej Viklicky

Jan Kvasniãka

Vladimír Teplan

Jifií Laacute;cha

Stefan Vítko

Patients with renal insufficiency are thought to be at higher risk for atherosclerotic complications, and pathogenesis of chronic kidney transplant rejection resembles, in some aspects, atherogenesis. In the present study, the authors evaluated risk factors for atherogenesis in patients with biopsy-proven chronic rejection and compared them with matched groups of transplant recipients without rejection and healthy Caucasians. Patients with chronic rejection had higher {alpha}-1-acid glycoprotein and fibrinogen, as well as soluble P-selectin concentration in the peripheral blood, as compared with patients with normal graft function. Surprisingly, the authors found no differences in E-selectin and ICAM-1. Moreover, they found patients with normal renal graft function to have higher acute phase proteins and P-selectin levels as compared with healthy persons. In conclusion, kidney transplant recipients are at increased risk for atherogenesis. Soluble P-selectin and acute phase proteins can be used for atherogenesis and/or chronic rejection monitoring in such patients.

Key Words: renal transplantation • chronic rejection • P-selectin • fibrinogen • {alpha}-1 acid glycoprotein

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?